Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,303 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Tumor Immune Microenvironment Is Associated With Recurrence in Early-Stage Lung Adenocarcinoma.
Kanemura H, Yokoyama T, Nakajima R, Nakamura A, Kuroda H, Kitamura Y, Shoda H, Mamesaya N, Miyata Y, Okamoto T, Okishio K, Oki M, Sakairi Y, Chen-Yoshikawa TF, Aoki T, Ohira T, Matsumoto I, Ueno K, Miyazaki T, Matsuguma H, Yokouchi H, Otani T, Ito A, Sakai K, Chiba Y, Nishio K, Yamamoto N, Okamoto I, Nakagawa K, Takeda M. Kanemura H, et al. Among authors: miyazaki t. JTO Clin Res Rep. 2024 Mar 8;5(4):100658. doi: 10.1016/j.jtocrr.2024.100658. eCollection 2024 Apr. JTO Clin Res Rep. 2024. PMID: 38651033 Free PMC article.
High expression of dihydropyrimidine dehydrogenase in lung adenocarcinoma is associated with mutations in epidermal growth factor receptor: implications for the treatment of non--small-cell lung cancer using 5-fluorouracil.
Mochinaga K, Tsuchiya T, Nagasaki T, Arai J, Tominaga T, Yamasaki N, Matsumoto K, Miyazaki T, Nanashima A, Hayashi T, Tsukamoto K, Nagayasu T. Mochinaga K, et al. Among authors: miyazaki t. Clin Lung Cancer. 2014 Mar;15(2):136-144.e4. doi: 10.1016/j.cllc.2013.09.002. Epub 2013 Nov 14. Clin Lung Cancer. 2014. PMID: 24405586
Presence of heat shock protein 47-positive fibroblasts in cancer stroma is associated with increased risk of postoperative recurrence in patients with lung cancer.
Miyamura T, Sakamoto N, Ishida K, Kakugawa T, Taniguchi H, Akiyama Y, Okuno D, Hara A, Kido T, Ishimoto H, Miyazaki T, Matsumoto K, Tsuchiya T, Yamaguchi H, Miyazaki T, Obase Y, Ishimatsu Y, Nagayasu T, Mukae H. Miyamura T, et al. Among authors: miyazaki t. Respir Res. 2020 Sep 14;21(1):234. doi: 10.1186/s12931-020-01490-1. Respir Res. 2020. PMID: 32928242 Free PMC article.
A randomized phase II study of S-1 monotherapy versus cisplatin with vinorelbine for completely resected stage II/IIIA non-small cell lung cancer: rationale and study protocol design for the LOGIK1702 study.
Tsuchiya T, Matsumoto K, Miyazaki T, Doi R, Tokunaga S, Yamaguchi H, Tomoshige K, Watanabe H, Nagayasu T, Sugio K. Tsuchiya T, et al. Among authors: miyazaki t. BMC Cancer. 2021 Mar 8;21(1):249. doi: 10.1186/s12885-021-07945-y. BMC Cancer. 2021. PMID: 33685421 Free PMC article.
The C-reactive protein to albumin ratio is a prognostic factor for stage I non-small cell lung cancer in elderly patients: JACS1303.
Miyazaki T, Saji H, Nakamura H, Nagayasu T, Okumura N, Tsuchida M, Sonobe M, Aokage K, Nakao M, Haruki T, Okada M, Suzuki K, Chida M, Yoshino I; Committee for Scientific Affairs, The Japanese Association for Chest Surgery. Miyazaki T, et al. Surg Today. 2022 Oct;52(10):1463-1471. doi: 10.1007/s00595-022-02485-9. Epub 2022 Feb 24. Surg Today. 2022. PMID: 35211804
Long-term outcomes and early recurrence after resection for metachronous pulmonary metastases from colorectal cancer.
Hashimoto S, Tominaga T, Nonaka T, Noda K, Kiya S, Shiraishi T, Oishi K, Takamura Y, Yamazaki S, Araki M, Sumida Y, Miyazaki T, Kamohara R, Morino S, Matsumoto K, Nakamura A, Nagayasu T. Hashimoto S, et al. Among authors: miyazaki t. Langenbecks Arch Surg. 2023 Dec 29;409(1):24. doi: 10.1007/s00423-023-03209-4. Langenbecks Arch Surg. 2023. PMID: 38158429
A multicenter phase II study of adjuvant chemotherapy with oral fluoropyrimidine S-1 for non-small-cell lung cancer: high completion and survival rates.
Tsuchiya T, Nagayasu T, Yamasaki N, Matsumoto K, Miyazaki T, Tagawa T, Nakamura A, Minami H, Taniguchi H, Akamine S, Hisano H, Taniguchi Y. Tsuchiya T, et al. Among authors: miyazaki t. Clin Lung Cancer. 2012 Nov;13(6):464-9. doi: 10.1016/j.cllc.2012.01.005. Epub 2012 Mar 14. Clin Lung Cancer. 2012. PMID: 22424872 Clinical Trial.
4,303 results